The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells
Open accessAbstract
Endocannabinoids are released after brain injury and believed to attenuate neuronal damage by binding to CB(1) receptors and protecting against excitotoxicity. Such excitotoxic brain lesions initially result in primary destruction of brain parenchyma, which attracts macrophages and microglia. These inflammatory cells release toxic cytokines and free radicals, resulting in secondary neuronal damage. In this study, we show that the endocannabinoid system is highly activated during CNS inflammation and that the endocannabinoid anandamide (AEA) protects neurons from inflammatory damage by CB(1/2) receptor-mediated rapid induction of mitogen-activated protein kinase phosphatase-1 (MKP-1) in microglial cells associated with histone H3 phoshorylation of the mkp-1 gene sequence. As a result, AEA-induced rapid MKP-1 expression switches off MAPK signal transduction in microglial cells activated by stimulation of pattern recognition receptors. The release of AEA in injured CNS tissue might therefore represent a new mechanism of neuro-immune communication during CNS injury, which controls and limits immune response after primary CNS damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AEA inhibits microglial nitric oxide (NO) synthesis through the mitogen-activated protein kinase pathway (Eljaschewitsch et al, 2006) and inhibits tumor necrosis factor α (TNF-α) activation of the transcription nuclear factor kappa B (Sancho et al, 2003).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Eljaschewitsch et al, 2006
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585
Characterization of ameboid microglia isolated from developing mammalian brain
Giulian, D., & Baker, T. J. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02163.1986 · Cited by 1,300
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,280
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 899
Inflammation and glial responses in ischemic brain lesions
Stoll, G. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00034-3 · Cited by 811
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M. A., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 782
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
Panikashvili, D., Simeonidou, C., Ben‐Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Galve‐Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 686
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L. M., Franklin, A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 674
Self-citationModulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
Alger, B. E. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 616
New concepts in the immunopathogenesis of multiple sclerosis
Hemmer, B., Archelos, J. J., & Hartung, H. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn784 · Cited by 598
Bouaboula, M., Poinot‐Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi, M. L., Fur, G. L., & Casellas, P. (1995) · Biochemical Journal · doi:10.1042/bj3120637 · Cited by 563
Brewer, G. J. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420510 · Cited by 546
Llano, I., Leresche, N., & Marty, A. (1991) · Neuron · doi:10.1016/0896-6273(91)90059-9 · Cited by 494
Pain modulation by release of the endogenous cannabinoid anandamide
Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 486
An immortalized cell line expresses properties of activated microglial cells
Bocchini, V., Mazzolla, R., Barluzzi, R., Blasi, E., Sick, P., & Kettenmann, H. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310405 · Cited by 367
Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus
Derkinderen, P., Valjent, E., Toutant, M., Corvol, J., Enslen, H., Ledent, C. A., Trzăskos, J. M., Caboche, J., & Girault, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02371.2003 · Cited by 350
Cannabinoids and neuroinflammation
Walter, L. M., & Stella, N. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705667 · Cited by 341
Functional CB1 cannabinoid receptors in human vascular endothelial cells
Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., & Kunos, G. (2000) · Biochemical Journal · doi:10.1042/bj3460835 · Cited by 339
Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336
Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis
Arévalo‐Martín, Á., Vela, J. M., Molina‐Holgado, E., Borrell, J. I., & Guaza, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 316
Behavioral Effects of Cannabinoid Agents in Animals
Chaperon, F., & Thiébot, M.-H. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i3.20 · Cited by 311
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296
Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor
Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi, M. L., Calandra, B., Fur, G. L., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 290
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
Facchinetti, F., Giudice, E. D., Furegato, S., Passarotto, M., & Leon, A. (2002) · Glia · doi:10.1002/glia.10177 · Cited by 280
Mabuchi, T., Kitagawa, K., Ohtsuki, T., Kuwabara, K., Yagita, Y., Yanagihara, T., Hori, M., & Matsumoto, M. (2000) · Stroke · doi:10.1161/01.str.31.7.1735 · Cited by 280
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 270
Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705304 · Cited by 251
Liu, J., Bátkai, S., Pacher, P., Harvey-White, J. D., Wagner, J. A., Cravatt, B. F., Gao, B., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306062200 · Cited by 234
Franklin, A., Parmentier‐Batteur, S., Walter, L. M., Greenberg, D. A., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07767.2003 · Cited by 232
Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 227
Control of the cell survival/death decision by cannabinoids
Guzmán, M., Sánchez, C., & Galve‐Roperh, I. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000177 · Cited by 223
Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration
Hansen, H. H., Schmid, P. C., Bittigau, P., Lastres‐Becker, I., Berrendero, F., Manzanares, J., Ikonomidou, C., Schmid, H. H. O., Fernández‐Ruiz, J. J., & Hansen, H. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00542.x · Cited by 215
The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
Rueda, D., Galve‐Roperh, I., Haro, A., & Guzmán, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.814 · Cited by 214
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
Killestein, J., Hoogervorst, E. L. J., Reif, M., Kalkers, N. F., Loenen, A. C. V., Staats, P. G. M., Gorter, R. W., Uitdehaag, B. M. J., & Polman, C. H. (2002) · Neurology · doi:10.1212/wnl.58.9.1404 · Cited by 210
Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling
Piomelli, D., & Greengard, P. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90182-8 · Cited by 194
P2X 7 receptors control 2-arachidonoylglycerol production by microglial cells
Witting, A., Walter, L. M., Wacker, J. L., Möller, T., & Stella, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306707101 · Cited by 191
Self-citationF‐ATPase: specific observation of the rotating c subunit oligomer of EFoEF1
Pänke, O., Gumbiowski, K., Junge, W., & Engelbrecht, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01436-8 · Cited by 189
Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
Derkinderen, P., Toutant, M., Burgaya, F., Bert, M. L., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 185
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
Russo, E. B. (2003) · Neurology · doi:10.1212/wnl.60.4.729-a · Cited by 184
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
Bouaboula, M., Bourrié, B., Rinaldi, M. L., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 176
The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
Wartmann, M., Campbell, D., Subramanian, A., BURSTEIN, S. H., & Davis, R. J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00027-7 · Cited by 176
Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1
Ullrich, O., Diestel, A., Eyüpoglu, I. Y., & Nitsch, R. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1035 · Cited by 175
Self-citationLi, J., Gorospe, M., Hutter, D., Barnes, J., Keyse, S. M., & Liu, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8213-8224.2001 · Cited by 173
Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 168
Gallily, R., Breuer, A., & Mechoulam, R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00653-1 · Cited by 163
Diestel, A., Aktas, O., Hackel, D., Häke, I., Meier, S., Raine, C. S., Nitsch, R., Zipp, F., & Ullrich, O. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030975 · Cited by 155
Self-citationAnandamide induces apoptosis of PC‐12 cells: involvement of superoxide and caspase‐3
Sarker, K. P., Obara, S., Nakata, M., Kitajima, I., & Maruyama, I. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01425-3 · Cited by 151
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds
Howlett, A. C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90278-9 · Cited by 150
Laake, J. H., Haug, F. Š., Wieloch, T. W., & Ottersen, O. P. (1999) · Brain Research Protocols · doi:10.1016/s1385-299x(99)00021-5 · Cited by 149
Induction of tolerance in rat cortical neurons: hypoxic preconditioning
Bruer, U., Weih, M., Исаев, Н. К., Meisel, A., Ruscher, K., Bergk, A., Trendelenburg, G., Wiegand, F., Victorov, I. V., & Dirnagl, U. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00954-x · Cited by 131
Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic mice
Witting, A., Weydt, P., Hong, S. Y., Kliot, M., Möller, T., & Stella, N. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02544.x · Cited by 112
Self-citationFranklin, A., & Stella, N. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02074-0 · Cited by 111
Trettel, J., & Levine, E. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01037.2002 · Cited by 109
Methods to induce primary and secondary traumatic damage in organotypic hippocampal slice cultures
Adamchik, Y., Frantseva, M. V., Weisspapir, M., Carlen, P. L., & Perez Velazquez, J. L. (2000) · Brain Research Protocols · doi:10.1016/s1385-299x(00)00007-6 · Cited by 101
Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability
Jacobsson, S. O. P., Rongård, E., Stridh, M., Tiger, G., & Fowler, C. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00492-5 · Cited by 94
Guo, Y., Kang, B., & WILLIAMSON, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10362 · Cited by 83
Heppner, F. L., Skutella, T., Hailer, N. P., Haas, D., & Nitsch, R. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00379.x · Cited by 78
Self-citationEmerging properties of cannabinoid medicines in management of multiple sclerosis
Pryce, G., & Baker, D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.03.006 · Cited by 76
Cannabinoids and neuroprotection in CNS inflammatory disease
Jackson, S. J., Diemel, L. T., Pryce, G., & Baker, D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.002 · Cited by 70
Shapiro, P. S., & Ahn, N. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1788 · Cited by 68
Stout Guards of the Central Nervous System
Mechoulam, R., & Lichtman, A. H. (2003) · Science · doi:10.1126/science.1091256 · Cited by 67
Biosynthesis and turnover of anandamide and other N‐acylethanolamines in peritoneal macrophages
Kuwae, T., Shiota, Y., Schmid, P. C., Krebsbach, R. J., & Schmid, H. H. O. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01226-0 · Cited by 41
Thompson, A. J., & Baker, D. (2002) · Neurology · doi:10.1212/wnl.58.9.1323 · Cited by 15
Research works printed but not linked: 1
- Matsuda, 1988, Structure of a cannabinoid receptor in rat brain, Mol. Pharmacol., 34, 605
Cited by
Sorted by citations
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,595
Pathological and protective roles of glia in chronic pain
Milligan, E. D., & Watkins, L. R. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2533 · Cited by 1,443
MAPK phosphatases — regulating the immune response
Liu, Y., Shepherd, E. G., & Nelin, L. D. (2007) · Nature reviews. Immunology · doi:10.1038/nri2035 · Cited by 679
Metadata
- Authors
- Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., & Ullrich, O.
- Affiliations
- Otto-von-Guericke-Universität Magdeburg (DE)
- University of Washington (US)
- Charité – Universitätsmedizin Berlin (DE)
- Max Delbrück Center (DE)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Ullrich, Oliver
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 49
- Issue
- 1
- Pages
- 67-79
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1968740815
- Cited by
- 445
- References
- 76
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 12 · 2023: 14 · 2022: 26 · 2021: 17 · 2020: 10 · 2019: 16 · 2018: 13 · 2017: 18 · 2016: 25 · 2015: 29 · 2014: 23 · 2013: 20 · 2012: 31
- FWCI
- 23.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- University of Miami
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- National Heart, Lung, and Blood Institute (N01-HO-3284)
- National Institute of Mental Health (R24-MH-59724, R24MH059724)
- National Institute of Neurological Disorders and Stroke (NS-08952, NS-11920, R01NS008952)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- anandamide, endocannabinoid system, MKP-1, microglia, neuroinflammation, neuroprotection, CB1 receptor, CB2 receptor, MAPK signaling, histone H3 phosphorylation, neuroimmune interactions, pattern recognition receptors, excitotoxicity, secondary neuronal damage
- MeSH terms
- Adult, Animals, Arachidonic Acids, Cell Survival, Cells, Cultured, Encephalitis, Humans, Middle Aged, Multiple Sclerosis, Neurons, Nitric Oxide, Phosphoprotein Phosphatases, Phosphorylation, Tissue Distribution, Protein Tyrosine Phosphatases, Rats, Wistar, Microglia, Immediate-Early Proteins, Neuroprotective Agents, Cell Cycle Proteins, Nitric Oxide Synthase, MAP Kinase Signaling System, Receptors, Cannabinoid, Extracellular Signal-Regulated MAP Kinases, Mice, Rats, Polyunsaturated Alkamides, Dual Specificity Phosphatase 1, Protein Phosphatase 1, Cannabinoid Receptor Modulators, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review